At AVAC, we are especially pleased that one of the seven papers highlights the essential role of community engagement, referencing the Good Participatory Practice (GPP) guidelines, to improve research conduct and outcomes. This paper—Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practice—is co-authored by AVAC’s Stacey Hannah and Jessica Salzwedel and partner, Catherine Slack of the HIV/AIDS Vaccine Ethics Group in South Africa. (For more about GPP, be sure to check out our online GPP Body of Evidence.)
We hope you will look out for the series of papers later today and join the conversation Friday to learn more about WHO’s call to make engagement central to clinical trials. Together we will discuss systemic gaps, structural inequities, and solutions—including stronger policies, increased funding, better regulatory oversight, and a research culture that integrates GPP as essential to future clinical trials around the world.
|
